Endocrinology Medical News about Malignant Pheochromocytoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Treatment of Malignant Pheochromocytoma
Hormone and Metabolic Research, 08/12/09

Adjalle R et al. – The most effective chemotherapy regimen appears to be the CVD–scheme, including cyclophosphamide, vincristine, and dacarbazine. The so–called targeted molecular therapies with treatment combinations of temozolomide and thalidomide, or sunitinib monotherapy, and novel therapeutic somatostatin analogues have shown promising results and should thus encourage clinical trials to improve the prognosis of metastatic PCC.

<< Previous
Should diuretics always be included as initial antihypertensive...

Next >>
Surgeon-Performed Ultrasound can Predict Differentiated Thyroid...